Enbrel and Alavert drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enbrel (etanercept) and Alavert (loratadine). Common drug interactions include dyslipidaemia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Enbrel and Alavert. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.

What is Alavert?

Alavert has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 2,062 Alavert users. Check the latest studies of Alavert.

On Jul, 15, 2026

12 people who take Enbrel and Alavert together, and have interactions are studied.

What are the common drug interactions of Enbrel and Alavert, by gender? *:

female:

Dyslipidaemia (abnormal amount of lipids)
Exostosis (formation of new bone on the surface of a bone)
Influenza like illness
Injection site pain
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Oedema peripheral (superficial swelling)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Pyuria (a condition of urine containing pus)
Red blood cell sedimentation rate increased
Asthma

male:

Drug ineffective
Premature delivery
Psoriasis (immune-mediated disease that affects the skin)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Therapeutic response decreased (less preventive response)

What are the common drug interactions of Enbrel and Alavert, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Full blood count increased
Injection site bruising
Injection site reaction
Psoriasis (immune-mediated disease that affects the skin)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Therapeutic response decreased (less preventive response)

40-49:

Hypersensitivity
Sinusitis (inflammation of sinus)
Drug ineffective
Premature delivery

50-59:

Malaise (a feeling of general discomfort or uneasiness)
Muscle spasms (muscle contraction)
Oligomenorrhoea (infrequent (or, in occasional usage, very light) menstruation)
Pain
Pneumonia
Upper-airway cough syndrome
Urinary tract infection
Uveitis (inflammation of the uvea)
Viral infection
Sinusitis (inflammation of sinus)

60+:

Injection site erythema (redness at injection site)
Injection site rash

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 4 people, 33.33%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 25.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 16.67%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 1 person, 8.33%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 8.33%
Immunodeficiency Common Variable: 1 person, 8.33%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and Alavert?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously